Preclinical evaluation of AL-001, a gene therapy for wet age-related macular degeneration.

Liu X, Liu H, Wang L, Zhao J, Xie X, Jiang L, Zhao CA

Open source

DOI
10.3389/fgene.2026.1836684
Published
2026
Container
Frontiers in genetics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fgene.2026.1836684,
  title = {Preclinical evaluation of AL-001, a gene therapy for wet age-related macular degeneration.},
  author = {Liu X and Liu H and Wang L and Zhao J and Xie X and Jiang L and Zhao CA},
  year = {2026},
  journal = {Frontiers in genetics},
  doi = {10.3389/fgene.2026.1836684},
  url = {https://doi.org/10.3389/fgene.2026.1836684}
}

RIS

TY  - JOUR
TI  - Preclinical evaluation of AL-001, a gene therapy for wet age-related macular degeneration.
AU  - Liu X
AU  - Liu H
AU  - Wang L
AU  - Zhao J
AU  - Xie X
AU  - Jiang L
AU  - Zhao CA
PY  - 2026
JO  - Frontiers in genetics
DO  - 10.3389/fgene.2026.1836684
UR  - https://doi.org/10.3389/fgene.2026.1836684
ER  - 

APA

X, L., H, L., L, W., J, Z., X, X., L, J., & CA, Z. (2026). Preclinical evaluation of AL-001, a gene therapy for wet age-related macular degeneration.. Frontiers in genetics. https://doi.org/10.3389/fgene.2026.1836684

Source records